Fostering New Advances in Lung Cancer Research

A diverse group of about 220 physicians, patient advocates, and scientists in basic, translational, and clinical lung cancer research will convene in San Diego for an international conference organized by the American Association for Cancer Research (AACR) and the International Association for the Study of Lung Cancer (IASLC). The focus of the conference is “Lung Cancer Translational Science from the Bench to the Clinic.”

Read More

Experts Forecast Cancer Research and Treatment Advances in 2018

This past year has been a year of many “firsts” for the oncology community, with several revolutionary advances in the research and treatment of cancer, We asked experts in the fields of immunotherapy, precision medicine, and prevention and disparities research where the cancer research community is headed next and what major accomplishments we might expect in 2018 to take us closer to conquering cancer.

Read More

Reflections on a Year of Progress in Cancer Research

As 2017 draws to a close, I’ve been reflecting on another year in cancer research. As Chief Executive Officer of the American Association for Cancer Research, I am privileged to witness some of the most exciting discoveries that bring us closer to preventing and curing the complex set of diseases we call cancer.

Read More

A Young Chemical Biologist Forges a Career Path in Cancer Research

When we think about “cancer scientists,” we typically conjure images of physicians treating their patients or biologists analyzing cells under a microscope. But cancer scientists can be found in fields beyond medicine and biology, from physics to chemistry to mathematics.

Read More

Could Genomics Influence Prostate Cancer Treatment?

Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed with prostate cancer have a tumor that grows very slowly, making it very unlikely that the disease will progress to become a clinical problem. Characterizing new ways to identify these cancers is an area of active research investigation.

Read More

Biosimilars: Breaking Through to Cancer Treatment

A little-talked-about provision of the 2010 Patient Protection and Affordable Care Act designed to improve access to innovative medical therapies has recently borne fruit for the cancer community in the form of two new therapeutic options for a wide range of cancers—bevacizumab-awwb (Mvasi) and trastuzumab-dkst (Ogivri).

Read More

SABCS Marks 40 Years

Kent Osborne, MD, a codirector of SABCS, wrote a guest post for Cancer Research Catalyst in 2015 that details the symposium’s growth. We’re happy to present it again. Check back with Cancer Research Catalyst frequently for updates from SABCS, which will take place Dec. 5-9.

Read More